EPISODE · Mar 3, 2026 · 12 MIN
Episode#10 Mar 03th 2026: Senhwa-CellType Collaboration, Generate's IPO
from Pharma Digest · host Jan Majta
Senhwa's CX-4945 targets CK2 kinase with dual tumor and immune modulatory mechanisms; CellType's AI platform aims to expand indications and improve clinical success via multi-omics analysis and translational validation.Generate's $400M IPO signals strong investor confidence, driven by AI-designed pipelines including GB-0895, an AI-optimized TSLP inhibitor with potential to disrupt asthma treatment.hysiology remains foundational for translating AI and sensor data into clinically relevant therapies, aiding in anticipating off-target effects and enhancing regulatory acceptance.
NOW PLAYING
Episode#10 Mar 03th 2026: Senhwa-CellType Collaboration, Generate's IPO
No transcript for this episode yet
Similar Episodes
May 9, 2026 ·109m
May 4, 2026 ·9m
Apr 27, 2026 ·12m
Apr 20, 2026 ·72m